Cargando…

Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma

Detalles Bibliográficos
Autores principales:	Branch, Kevin, Adusumilli, Prasad S., Zauderer, Marjorie G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989819/ https://www.ncbi.nlm.nih.gov/pubmed/36895927 http://dx.doi.org/10.21037/tlcr-23-46

Ejemplares similares

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment
por: Aprile, Vittorio, et al.
Publicado: (2021)

Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021)

Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
por: Zhao, Zi-Yi, et al.
Publicado: (2017)

Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
por: Järvinen, Tommi, et al.
Publicado: (2021)

Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis
por: Jun, Su Youn, et al.
Publicado: (2017)

Evolving Landscape of Initial Treatments for Patients with Malignant Pleural Mesotheliomas: Clinical Trials to Clinical Practice
por: Offin, Michael, et al.
Publicado: (2022)

Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure
por: Ramegowda, Jalaja Koppa, et al.
Publicado: (2015)

Salvage debulking surgery and hyperthermic intrathoracic chemotherapy for massive recurrent mesothelioma in the mediastinum
por: Poon, Shi Sum, et al.
Publicado: (2022)

Surgical cytoreduction and hyperthermic intrathoracic chemotherapy for thymic tumours with pleural spread is effective on survival: results from the multicentre German hyperthermic intrathoracic chemotherapy study
por: Ried, Michael, et al.
Publicado: (2023)

The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
por: Zauderer, Marjorie G.
Publicado: (2021)

Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion
por: Li, Zihui, et al.
Publicado: (2023)

The Excretion of Cisplatin after Hyperthermic Intrathoracic Chemotherapy
por: Larisch, Christopher, et al.
Publicado: (2023)

Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study
por: Migliore, Marcello, et al.
Publicado: (2023)

Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis
por: Zhou, Hua, et al.
Publicado: (2017)

Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study
por: Ried, Michael, et al.
Publicado: (2021)

Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)

Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
por: Eguchi, Takashi, et al.
Publicado: (2017)

Present and future of hyperthermic intrathoracic chemotherapy (HITHOC) in thoracic surgical oncology
por: Migliore, Marcello
Publicado: (2021)

Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy
por: Markowiak, Till, et al.
Publicado: (2021)

Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment
por: Ban, Cheng-Jun, et al.
Publicado: (2017)

Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion
por: Kerscher, Christoph, et al.
Publicado: (2014)

Cardiac output and oxygen delivery are affected by intraoperative hyperthermic intrathoracic chemotherapy
por: Scolletta, S, et al.
Publicado: (2008)

A narrative review of hyperthermic intrathoracic chemotherapy for advanced lung cancer
por: Song, Kimberly, et al.
Publicado: (2021)

Survival of pleurectomy-decortication and hyperthermic chemotherapy in mesothelioma
por: Ergönül, Ayşe Gül, et al.
Publicado: (2023)

Localized malignant pleural mesothelioma with renal metastasis
por: Zardawi, Sarah Jane, et al.
Publicado: (2015)

Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy
por: Li, Xiaoyu, et al.
Publicado: (2019)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma
por: Chintala, Navin K., et al.
Publicado: (2023)

Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis
por: Karampinis, Ioannis, et al.
Publicado: (2022)

Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany
por: Markowiak, Till, et al.
Publicado: (2020)

Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library
por: Offin, Michael, et al.
Publicado: (2022)

The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study
por: Zauderer, Marjorie G, et al.
Publicado: (2021)

Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies
por: Markowiak, Till, et al.
Publicado: (2021)

Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report
por: Bongiolatti, Stefano, et al.
Publicado: (2021)

Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0–N1 nonsmall cell lung cancer and malignant pleural effusion?
por: Migliore, Marcello, et al.
Publicado: (2019)

Technique of pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural effusion
por: Drevet, Gabrielle, et al.
Publicado: (2020)

Malignant Pleural Mesothelioma: Time Is Running Out
por: Lococo, Filippo
Publicado: (2021)

Multimodal treatment for resectable epithelial type malignant pleural mesothelioma
por: Yoshino, Ichiro, et al.
Publicado: (2004)

Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma
por: Sayan, Muhammet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kc557vmlfh9q51076kboima0s4